Organelle最新文献

筛选

英文中文

Regulation of mitochondrial function by FOXOs in ischemic stroke and Alzheimer’s disease 缺血性中风和阿尔茨海默病中 FOXOs 对线粒体功能的调控

Organelle Pub Date : 2024-05-15 DOI: 10.61747/0ifp.202403001

Yasin Asadi, Hongmin Wang

{"title":"Regulation of mitochondrial function by FOXOs in ischemic stroke and Alzheimer’s disease","authors":"Yasin Asadi, Hongmin Wang","doi":"10.61747/0ifp.202403001","DOIUrl":"https://doi.org/10.61747/0ifp.202403001","url":null,"abstract":"Transcriptional control is a pivotal mechanism governing various cellular processes. FOXO proteins, a subgroup of the forkhead family of transcription factors, play a key role in determining cell fate. The localization and function of FOXO proteins are regulated by post-translational modifications to control target gene expression, with a pronounced impact on various aspects of mitochondrial function, including mitochondrial dynamics, biogenesis, and quality control. Mitochondria stand out as the primary target of FOXO transcription factors, which recruit downstream signaling factors to govern mitochondrial processes. Essential signaling pathways are modulated by FOXOs, exemplified by their regulation of mitochondrial biogenesis through SIRT1-Pgc1a and NRF1-TFAM, as well as their influence on mitochondrial dynamics involving Mfn1, Mfn2, Drp1, and Fis1. Furthermore, FOXOs demonstrate the ability to upregulate and downregulate genes that serve as modulators in oxidative and apoptosis cascades. The functional role of FOXO proteins is highly context-dependent, varying with cell type, organ, and specific FOXO isoform. Notably, FOXOs emerge as prominent players in various pathological conditions, including ischemic conditions, neurodegenerative diseases, cancer, and metabolic disorders. Unraveling the complex role of FOXOs in mammalian cell pathology positions them as promising therapeutic targets receptive to pharmacological treatment. This review aims to provide insights into the intricate roles of FOXOs in mitochondria, illuminating their potential as therapeutic targets amenable to pharmacological intervention in diverse pathological contexts, particularly in ischemic stroke and Alzheimer’s disease.","PeriodicalId":508836,"journal":{"name":"Organelle","volume":"51 25","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140972871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Intricate roles of spacers and stickers of Arg-rich C9ORF72 dipeptide repeat proteins; from toxicity to targeting to membraneless organelles 富含 Arg 的 C9ORF72 二肽重复蛋白的间隔和粘连的复杂作用；从毒性到无膜细胞器的靶向性

Organelle Pub Date : 2023-12-13 DOI: 10.61747/0ifp.202311001

Kohsuke Kanekura, Tamami Miyagi

引用次数: 0